The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 13, 2021

Filed:

Nov. 20, 2019
Applicant:

W. L. Gore & Associates, Inc., Newark, DE (US);

Inventor:

Michael C. McManaway, Cecilton, MD (US);

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
B01D 15/38 (2006.01); B01J 20/286 (2006.01); B01J 20/28 (2006.01); B01D 15/22 (2006.01); B01D 69/14 (2006.01); B01J 20/06 (2006.01); B01J 20/26 (2006.01); B01J 20/10 (2006.01); B01D 63/08 (2006.01); B01D 63/10 (2006.01); B01D 69/02 (2006.01); C07K 1/22 (2006.01); C07K 16/00 (2006.01);
U.S. Cl.
CPC ...
B01D 15/3809 (2013.01); B01D 15/22 (2013.01); B01D 63/082 (2013.01); B01D 63/10 (2013.01); B01D 69/02 (2013.01); B01D 69/148 (2013.01); B01J 20/06 (2013.01); B01J 20/103 (2013.01); B01J 20/262 (2013.01); B01J 20/286 (2013.01); B01J 20/28035 (2013.01); B01J 20/28052 (2013.01); C07K 1/22 (2013.01); C07K 16/00 (2013.01); B01D 2313/08 (2013.01); B01D 2313/40 (2013.01); B01D 2325/12 (2013.01);
Abstract

The present invention is directed to affinity chromatography devices that separate a targeted protein or antibody from an aqueous mixture containing the targeted protein or antibody. The chromatography device may contain a stacked membrane assembly or a wound membrane assembly. The membrane assemblies include at least one polymer membrane that contains therein inorganic particles. The polymer membrane and/or the inorganic particles have an affinity ligand bonded thereto. The affinity ligand may be a protein, an antibody, or a polysaccharide that reversibly binds to the targeted protein or antibody. The chromatography device may be repeatedly used and may be cleaned with a caustic solution between uses. The chromatography devices may have a dynamic binding capacity (DBC) of at least 30 mg/ml (or 0.07 micromol/ml) at 10% breakthrough at a residence time of 20 seconds or less.


Find Patent Forward Citations

Loading…